What the six lenses say about PPLPHARMA — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How PPLPHARMA’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +3.0pp | +3.7pp | +9.0pp | +30.0pp | +47.4pp | +14.4pp |
Nifty 500 Broad-market baseline | +3.0pp | +3.7pp | +7.9pp | +28.4pp | +41.6pp | +9.2pp |
Sector Own-sector index | — | — | +5.1pp | +22.4pp | +28.5pp | -11.6pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
PPLPHARMA daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
PPLPHARMA ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 1,951 | 2,242 | 2,204 | 2,754 | 1,934 | 2,044 | 2,140 | 2,752 |
| ↳ change QoQ | — | +14.9% | -1.7% | +24.9% | -29.8% | +5.7% | +4.7% | +28.6% |
| EBITDA (₹cr) | 224 | 403 | 350 | 561 | 107 | 159 | 196 | 461 |
| EBITDA margin | 11.5% | 18.0% | 15.9% | 20.4% | 5.5% | 7.8% | 9.2% | 16.7% |
| PAT (₹cr) | -89 | 23 | 4 | 154 | -82 | -99 | -136 | -9 |
| ↳ change QoQ | — | +125.5% | -83.7% | +4071.2% | -153.2% | -21.4% | -37.3% | +93.5% |
| Net margin | -4.5% | 1.0% | 0.2% | 5.6% | -4.2% | -4.9% | -6.4% | -0.3% |
| EPS (₹) | -0.67 | 0.17 | 0.03 | 1.16 | -0.61 | -0.75 | -1.02 | -0.07 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding PPLPHARMA (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| HDFC Flexi Cap Gr | 1.38% | 1,10,736 | |
| Bandhan Small Cap Reg Gr | 0.62% | 31,103 | |
| Franklin India Small Cap Gr | 0.69% | 14,467 | |
| Canara Robeco Small Cap Reg Gr | 1.21% | 14,231 | |
| Canara Robeco Equity Hyb Reg Gr | 0.54% | 11,371 | |
| Nippon India Pharma Bns | 2.09% | 9,279 | |
| Nippon India Pharma Gr | 2.09% | 9,279 | |
| Canara Robeco ELSS Tax Saver Reg Gr | 0.65% | 8,758 | |
| Bajaj Finserv Flexi Cap Reg Gr | 1.37% | 8,173 | |
| Franklin India Multi Cap Reg Gr | 0.76% | 5,096 |
ETFs holding PPLPHARMA (10)